Table 5.
Baseline characteristics of participants relative to development of CKD during the 6-year follow-up period
| CKD (n = 227) |
Without CKD (n = 4956) |
P value | |
|---|---|---|---|
| Age (Years) | 72(23) | 47(22) | < 0.001 |
| Male (%) | 139(61.2) | 3037(61.3) | 0.989 |
| BMI (kg/m2) | 24.32 ± 2.78 | 23.18 ± 3.01 | < 0.001 |
| SBP (mmHg) | 139.80 ± 20.81 | 124.91 ± 18.79 | < 0.001 |
| DBP (mmHg) | 80.61 ± 12.02 | 75.31 ± 11.21 | < 0.001 |
| TG (mmol/L) | 1.71 ± 1.29 | 1.42 ± 1.11 | 0.001 |
| ΔTG | 0.25 ± 0.28 | 0.11 ± 0.16 | < 0.001 |
| TC (mmol/L) | 5.12 ± 1.02 | 4.83 ± 0.91 | < 0.001 |
| ΔTC (mmol/L) | 0.27 ± 0.36 | 0.15 ± 0.23 | < 0.001 |
| HDL-C (mmol/L) | 1.31 ± 0.28 | 1.30 ± 0.31 | 0.048 |
| LDL (mmol/L) | 2.98 ± 0.82 | 2.82 ± 0.77 | < 0.001 |
| ΔLDL (mmol/L) | 0.15 ± 0.25 | 0.08 ± 0.19 | < 0.001 |
| BUN (mmol/L) | 5.68 ± 1.17 | 4.96 ± 1.14 | < 0.001 |
| FPG (mmol/L) | 5.46 ± 1.01 | 5.24 ± 0.82 | < 0.001 |
| SUA (mg/dl) | 6.24 ± 1.41 | 5.59 ± 1.33 | < 0.001 |
| Hypertension (%) | 103(45.4) | 746(15.1) | < 0.001 |
| Diabetes (%) | 25(11.0) | 173(3.5) | < 0.001 |
| Baseline eGFR (ml/min/1.73m2) | 68.71 ± 7.62 | 87.01 ± 15.12 | < 0.001 |
| Ending eGFR (ml/min/1.73m2) | 48.75 ± 8.76 | 72.38 ± 10.99 | < 0.001 |
ΔTG, ΔTC and ΔLDL-C: ending TG/ TC/ LDL minus baseline TG/ TC/ LDL, respectively